Abstract: Magnetic calcium phosphate particles are provided including particles comprising iron oxide and calcium phosphate. A chitosan coating is present on the particles, wherein the particles are less than or equal to 1,000 nm, are magnetic and exhibit a positive charge in the range of 1 mVolts to 60 mVolts. The particles are provided by preparing a calcium hydroxide solution and filtering the calcium hydroxide solution in a membrane filter. An iron chloride solution is formed and combined with the filtered calcium hydroxide solution. In addition, the phosphoric acid solution is combined with the combined solutions of iron chloride and calcium hydroxide, forming a mixture including particles comprising iron oxide and calcium phosphate.

Abstract: Magnetic calcium phosphate particles are provided including particles comprising iron oxide and calcium phosphate. A chitosan coating is present on the particles, wherein the particles are less than or equal to 1,000 nm, are magnetic and exhibit a positive charge in the range of 1 mVolts to 60 mVolts. The particles are provided by preparing a calcium hydroxide solution and filtering the calcium hydroxide solution in a membrane filter. An iron chloride solution is formed and combined with the filtered calcium hydroxide solution. In addition, the phosphoric acid solution is combined with the combined solutions of iron chloride and calcium hydroxide, forming a mixture including particles comprising iron oxide and calcium phosphate.

Abstract: The present invention is directed to nanoparticle-based targeted drug delivery system for treatment of bone-loss. An enantiomeric phenothiazine is formulated into an in-vivo nanoparticle delivery system which may contain bone-targeting functionality. The nanoparticle formulations and their associated influence on whole bone porosity may now also be evaluated utilizing nuclear magnetic resonance (NMR) and relaxation time profiles, and in particular, median T2 relaxation times.

Abstract: Magnetic resonance technology can be used to non-invasively measure bone porosity, pore size distribution, and other bone properties, including aging, in situ. Spin-lattice (T1) as well as spin-spin (T2) relaxation time data and spectra are used to determine porosity and pore size distribution in human bones, including compact bones.

Abstract: A method and apparatus (10) for detecting and measuring the amount of crude oil in underground rock formations. EPR measurements are used to calculate the amount of crude oil, and may be calibrated to determine the particular type of crude oil. These measurements may be used in conjunction with NMR measurements, to provide accurate estimations of pore size and permeability.

Abstract: Magnetic resonance technology can be used to non-invasively measure bone porosity, pore size distribution, and other bone properties, including aging, in situ. Spin-lattice (T1) as well as spin-spin (T2) relaxation time data and spectra are used to determine porosity and pore size distribution in human bones, including compact bones.

Abstract: A method and apparatus (10) for detecting and measuring the amount of crude oil in underground rock formations. EPR measurements are used to calculate the amount of crude oil, and may be calibrated to determine the particular type of crude oil. These measurements may be used in conjunction with NMR measurements, to provide accurate estimations of pore size and permeability.

Abstract: Various flowmeters (10, 70, 110, 120) each have an ESR sensor (13, 73, 112, 121) for measuring the crude oil fraction and/or velocity of a fluid containing crude oil. In combination with an NMR sensor or other sensors, a complete set of flow fraction, flow velocity, and flow rate measurements can be obtained for multiphase fluids containing gas, oil, water or any combination thereof.

Abstract: Various flowmeters (10, 70, 80) each have at least one NMR sensor (12, 72, 82) for measuring the various flow parameters of a flowing fluid. The NMR sensor may be used to provide a gradient magnetic field, which provides separate velocities when the fluid is multiphase (FIG. 10). The flowmeters may also be used to measure flow rate directly. The flowmeters may also be used to determine the separate flow fractions of a multiphase fluid.